The Tau Of Alzheimer's
    By Hank Campbell | November 12th 2012 02:31 PM | 2 comments | Print | E-mail | Track Comments

    Comments

    From reading the link, I suspect both camps are wrong about Alzheimer's. Part of the problem is the focus on attempting to develop a lucrative drug before understanding the roots of the disease.
    Gerhard Adam
    Investors are the new "peer-review".  After all, we saw how much effort went into understanding Alzheimer's versus developing the drug by this statement.
    But TauRx didn't publish a full set of data from the trial, causing some skepticism among researchers. (Dr. Wischik says it didn't to protect the company's commercial interests).
    http://online.wsj.com/article/SB10000872396390443624204578060941988428604.html
    Nothing like good old scientific objectivity.
    With his passionate beliefs, Dr. Wischik admits he may be just as much a zealot about tau as he accuses others of being about beta amyloid. "I may be," he says. "In the end…it's down to the phase 3 trial."
    ...and thus we have the marriage between commercial interests and religous fervor.
    Mundus vult decipi